CAN
DNA icon

Cetera Advisor Networks’s Ginkgo Bioworks DNA Stock Holding History

Cetera Advisor Networks’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.15M Buy
46,368
+31,330
+208% +$1.62M 0.01% 986
2023
Q4 		$1.02M Buy
15,038
+13,053
+658% +$799K 0.01% 1363
2023
Q3 		$144K Buy
1,985
+1,607
+425% +$128K ﹤0.01% 2503
2023
Q2 		$28.1K Sell
378
-13
-3% -$770 ﹤0.01% 2545
2023
Q1 		$20.8K Sell
391
-419
-52% -$26.6K ﹤0.01% 2530
2022
Q4 		$54.8K Buy
+810
New +$74.5K ﹤0.01% 2435

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cetera Advisor Networks's DNA Position: Q1 2024 in Review

Cetera Advisor Networks increased its Ginkgo Bioworks (DNA) stake by 208% in Q1 2024, buying an estimated $1.62M and bringing the position to 46,368 shares worth $2.15M. The position accounts for 0.01% of the portfolio, ranked #986.

Cetera Advisor Networks first reported a position in DNA in Q4 2022 and has held it in 6 quarters since. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

  • Cetera Advisor Networks held 46,368 shares of Ginkgo Bioworks worth $2.15M as of Q1 2024.
  • Cetera Advisor Networks bought 31,330 Ginkgo Bioworks shares in Q1 2024, an estimated $1.62M.
  • Ginkgo Bioworks made up 0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #986 holding.
  • Cetera Advisor Networks first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 6 quarters since.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.